Gary R Ostroff

Author PubWeight™ 20.00^‹?›

Top papers

Rank	Title	Journal	Year	PubWeight™‹?›
1	Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation.	Nature	2009	3.21
2	Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.	J Immunol	2004	2.00
3	Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.	Cancer Res	2003	1.81
4	Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists.	Infect Immun	2009	1.29
5	Robust stimulation of humoral and cellular immune responses following vaccination with antigen-loaded beta-glucan particles.	MBio	2010	1.22
6	Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery.	Bioconjug Chem	2008	1.17
7	HTT-lowering reverses Huntington's disease immune dysfunction caused by NFκB pathway dysregulation.	Brain	2014	1.13
8	Relative contributions of dectin-1 and complement to immune responses to particulate β-glucans.	J Immunol	2012	1.07
9	Glucan particles for selective delivery of siRNA to phagocytic cells in mice.	Biochem J	2011	1.03
10	Linkage specificity and role of properdin in activation of the alternative complement pathway by fungal glycans.	MBio	2011	0.99
11	Construction and evaluation of a novel recombinant T cell epitope-based vaccine against Coccidioidomycosis.	Infect Immun	2012	0.97
12	A comparison of the pulmonary inflammatory potential of different components of yeast cell wall.	J Toxicol Environ Health A	2007	0.95
13	β-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination.	J Control Release	2013	0.90
14	Glucan particles for macrophage targeted delivery of nanoparticles.	J Drug Deliv	2011	0.89
15	Characterization and optimization of the glucan particle-based vaccine platform.	Clin Vaccine Immunol	2013	0.88
16	Exploiting fungal cell wall components in vaccines.	Semin Immunopathol	2014	0.80